Membrane Antioxidant Effects of the Charged Dihydropyridine Calcium Antagonist Amlodipine

Author： Mason R.P.   Walter M.F.   Trumbore M.W.   Olmstead Jr E.G.   Mason P.E.  

Publisher： Academic Press

ISSN： 0022-2828

Source： Journal of Molecular and Cellular Cardiology, Vol.31, Iss.1, 1999-01, pp. : 275-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improved Tolerability of the Dihydropyridine Calcium-Channel Antagonist Lercanidipine: The Lercanidipine Challenge Trial

By BORGHI CLAUDIO   PRANDIN MARIA GRAZIA   DORMI ADA   AMBROSIONI ETTORE  

Blood Pressure, Vol. 12, Iss. 1, 2003-01 ,pp. : 14-21

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Profile of Barnidipine: A Single Optical Isomer Dihydropyridine Calcium Antagonist

By VAN ZWIETEN PIETER A.  

Blood Pressure, Vol. 7, Iss. 1, 1998-06 ,pp. : 5-8

Informa Healthcare

Access to resources Recommend Favorite

Nicardipine: A Hypotensive Dihydropyridine-Type Calcium Antagonist with a Peculiar Cerebrovascular Profile

By Amenta Francesco   Tomassoni Daniele   Traini Enea   Mignini Fiorenzo   Veglio Franco  

Clinical and Experimental Hypertension, Vol. 30, Iss. 8, 2008-11 ,pp. : 808-826

Informa Healthcare

Access to resources Recommend Favorite

Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: A literature review comparing amlodipine and nifedipine GITS

By Toal Corey B.   Meredith Peter A.   Elliott Henry L.  

Blood Pressure, Vol. 21, Iss. 1, 2012-07 ,pp. : 3-10

Informa Healthcare

Access to resources Recommend Favorite

Atheroprotective Effects of Long-Acting Dihydropyridine-Type Calcium Channel Blockers: Evidence from Clinical Trials and Basic Scientific Research

By  

Cerebrovascular Diseases, Vol. 16, Iss. 3, 2003-06 ,pp. : 11-17

Karger

Access to resources Recommend Favorite